Substance Abuse Treatment Market By Substance Type (Alcohol, Opioids, Nicotine, Cocaine, Marijuana, Methamphetamines, Other), By Treatment Type (Opioid Treatments, Nicotine Treatments, Alcohol Treatments, Therapies, Others), By Age Group (Adolescents, Adults, Geriatric), By Treatment Setting (Outpatient Treatment, Inpatient Treatment, Residential Treatment Facilities, Detoxification Centers), and By End-User (Hospitals & Clinics, Rehabilitation Centers, Outpatient Clinics, Community Health Centers, Telehealth Platforms, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Substance Abuse Treatment Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How does increasing opioid and alcohol addiction prevalence boost treatment market growth?

3.2.2. How is rising awareness about substance abuse encouraging patients to seek therapy?

3.2.3. How do digital health platforms expand accessibility to substance abuse treatment globally?

3.3. Key industry pitfalls & challenges

3.3.1. How do high treatment costs limit patient access to substance abuse programs?

3.3.2. How does social stigma around addiction prevent individuals from seeking help?

3.3.3. How do regulatory hurdles slow the approval of new addiction therapies?

3.4. Market Opportunities

3.4.1. How can telemedicine and virtual therapy broaden substance abuse treatment reach?

3.4.2. How does growing government funding enhance development of new treatment centers?

3.4.3. How can personalized medicine improve efficacy and outcomes of addiction therapies?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Substance Abuse Treatment Market, Substance Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Substance Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Alcohol

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Opioids

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Nicotine

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Cocaine

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Marijuana

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Methamphetamines

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.8. Other

4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Substance Abuse Treatment Market, Treatment Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Treatment Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Opioid Treatments

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Nicotine Treatments

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Alcohol Treatments

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Therapies

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Substance Abuse Treatment Market, Age Group Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Age Group, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Adolescents

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Adults

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Geriatric

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Substance Abuse Treatment Market, Treatment Setting Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Treatment Setting, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Outpatient Treatment

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Inpatient Treatment

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Residential Treatment Facilities

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Detoxification Centers

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Substance Abuse Treatment Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals & Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Rehabilitation Centers

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Outpatient Clinics

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Community Health Centers

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Telehealth Platforms

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.7. Others

8.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Substance Abuse Treatment Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Substance Type, 2025-2035

9.2.3. North America Market Revenue, By Treatment Type, 2025-2035

9.2.4. North America Market Revenue, By Age Group, 2025-2035

9.2.5. North America Market Revenue, By Treatment Setting, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Substance Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Treatment Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Age Group, 2025-2035

9.2.7.4. U.S. Market Revenue, By Treatment Setting, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Substance Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Treatment Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Age Group, 2025-2035

9.2.8.4. Canada Market Revenue, By Treatment Setting, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Substance Type, 2025-2035

9.3.3. Europe Market Revenue, By Treatment Type, 2025-2035

9.3.4. Europe Market Revenue, By Age Group, 2025-2035

9.3.5. Europe Market Revenue, By Treatment Setting, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Substance Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Treatment Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Age Group, 2025-2035

9.3.7.4. Germany Market Revenue, By Treatment Setting, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Substance Type, 2025-2035

9.3.8.2. France Market Revenue, By Treatment Type, 2025-2035

9.3.8.3. France Market Revenue, By Age Group, 2025-2035

9.3.8.4. France Market Revenue, By Treatment Setting, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Substance Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Treatment Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Age Group, 2025-2035

9.3.9.4. U.K. Market Revenue, By Treatment Setting, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Substance Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Treatment Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Age Group, 2025-2035

9.3.10.4. Italy Market Revenue, By Treatment Setting, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Substance Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Treatment Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Age Group, 2025-2035

9.3.11.4. Spain Market Revenue, By Treatment Setting, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Substance Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Treatment Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Age Group, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Treatment Setting, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Substance Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Treatment Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Age Group, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Treatment Setting, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Substance Type, 2025-2035

9.4.7.2. China Market Revenue, By Treatment Type, 2025-2035

9.4.7.3. China Market Revenue, By Age Group, 2025-2035

9.4.7.4. China Market Revenue, By Treatment Setting, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Substance Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Treatment Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Age Group, 2025-2035

9.4.8.4. Japan Market Revenue, By Treatment Setting, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Substance Type, 2025-2035

9.4.9.2. India Market Revenue, By Treatment Type, 2025-2035

9.4.9.3. India Market Revenue, By Age Group, 2025-2035

9.4.9.4. India Market Revenue, By Treatment Setting, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Substance Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Treatment Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Age Group, 2025-2035

9.4.10.4. Australia Market Revenue, By Treatment Setting, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Substance Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Treatment Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Age Group, 2025-2035

9.4.11.4. South Korea Market Revenue, By Treatment Setting, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Substance Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Treatment Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Age Group, 2025-2035

9.4.12.4. Singapore Market Revenue, By Treatment Setting, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Substance Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Treatment Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Age Group, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Treatment Setting, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Substance Type, 2025-2035

9.5.3. Latin America Market Revenue, By Treatment Type, 2025-2035

9.5.4. Latin America Market Revenue, By Age Group, 2025-2035

9.5.5. Latin America Market Revenue, By Treatment Setting, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Substance Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Treatment Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Age Group, 2025-2035

9.5.7.4. Brazil Market Revenue, By Treatment Setting, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Substance Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Treatment Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Age Group, 2025-2035

9.5.8.4. Argentina Market Revenue, By Treatment Setting, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Substance Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Treatment Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Age Group, 2025-2035

9.5.9.4. Mexico Market Revenue, By Treatment Setting, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Substance Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Treatment Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Age Group, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Treatment Setting, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Substance Type, 2025-2035

9.6.3. MEA Market Revenue, By Treatment Type, 2025-2035

9.6.4. MEA Market Revenue, By Age Group, 2025-2035

9.6.5. MEA Market Revenue, By Treatment Setting, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Substance Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Treatment Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Age Group, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Treatment Setting, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Substance Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Treatment Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Age Group, 2025-2035

9.6.8.4. South Africa Market Revenue, By Treatment Setting, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Substance Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Treatment Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Age Group, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Treatment Setting, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Indivior PLC

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Alkermes PLC

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Mallinckrodt Pharmaceuticals

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Cipla Limited

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. GlaxoSmithKline PLC

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. BioCorRx, Inc.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. American Addiction Centers, Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Boulder Care, Inc.

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Charlie Health, Inc.

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Pear Therapeutics, Inc.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Hazelden Betty Ford Foundation

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Purdue Pharma L.P.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Johnson & Johnson

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Pfizer Inc.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Lundbeck A/S

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis